Jacobs & CO Laboratory Corp Of America Holdings Transaction History

Jacobs & CO

$1.01 Billion
Q2 2025

A detailed history of Jacobs & CO transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Jacobs & CO holds 24,552 shares of LH stock, worth $6.36 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

24,552

Previous 24,968 1.67%

Holding current value

$6.36 Million

Previous $5.81 Million 10.91%

% of portfolio

0.64%

Previous 0.62%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 02, 2025	SELL	$212.22 - $263.96 $88,283 - $109,807	-416 Reduced 1.67%	24,552 $6.45 Million
Q1 2025 Apr 02, 2025	SELL	$228.33 - $256.81 $78,773 - $88,599	-345 Reduced 1.36%	24,968 $5.81 Million
Q4 2024 Jan 10, 2025	BUY	$212.02 - $246.22 $25,442 - $29,546	120 Added 0.48%	25,313 $5.8 Million
Q3 2024 Oct 01, 2024	BUY	$199.35 - $236.0 $109,642 - $129,800	550 Added 2.23%	25,193 $5.63 Million
Q2 2024 Jul 12, 2024	BUY	$192.5 - $216.35 $195,002 - $219,162	1,013 Added 4.29%	24,643 $5.02 Million
Q1 2024 Apr 12, 2024	BUY	$209.01 - $232.56 $88,620 - $98,605	424 Added 1.83%	23,630 $5.16 Million
Q2 2023 Jul 11, 2023	SELL	$211.93 - $241.33 $127,158 - $144,798	-600 Reduced 2.52%	23,206 $5.6 Million
Q1 2023 Apr 17, 2023	SELL	$213.32 - $257.83 $150,817 - $182,285	-707 Reduced 2.88%	23,806 $5.46 Million
Q4 2022 Jan 13, 2023	SELL	$203.72 - $248.97 $8,148 - $9,958	-40 Reduced 0.16%	24,513 $5.77 Million
Q3 2022 Oct 11, 2022	SELL	$204.81 - $262.19 $23,553 - $30,151	-115 Reduced 0.47%	24,553 $5.03 Million
Q2 2022 Jul 19, 2022	SELL	$213.86 - $277.87 $415,743 - $540,179	-1,944 Reduced 7.3%	24,668 $5.78 Million
Q1 2022 Apr 14, 2022	SELL	$259.82 - $298.18 $41,571 - $47,708	-160 Reduced 0.6%	26,612 $7.02 Million
Q4 2021 Jan 21, 2022	SELL	$271.6 - $314.21 $93,158 - $107,774	-343 Reduced 1.26%	26,772 $8.41 Million
Q3 2021 Oct 13, 2021	BUY	$274.82 - $308.34 $79,697 - $89,418	290 Added 1.08%	27,115 $7.63 Million
Q2 2021 Jul 15, 2021	SELL	$251.87 - $278.14 $98,229 - $108,474	-390 Reduced 1.43%	26,825 $7.4 Million
Q1 2021 Apr 05, 2021	SELL	$204.88 - $255.03 $73,347 - $91,300	-358 Reduced 1.3%	27,215 $6.94 Million
Q4 2020 Jan 12, 2021	SELL	$186.91 - $214.42 $9,719 - $11,149	-52 Reduced 0.19%	27,573 $5.61 Million
Q3 2020 Dec 03, 2020	BUY	$167.03 - $201.3 $6,681 - $8,052	40 Added 0.15%	27,625 $5.2 Million
Q2 2020 Jul 09, 2020	BUY	$113.31 - $182.44 $74,784 - $120,410	660 Added 2.45%	27,585 $4.58 Million
Q1 2020 Apr 13, 2020	SELL	$104.32 - $195.28 $209,891 - $392,903	-2,012 Reduced 6.95%	26,925 $3.4 Million
Q4 2019 Jan 29, 2020	BUY	$163.48 - $173.61 $193,560 - $205,554	1,184 Added 4.27%	28,937 $4.9 Million
Q3 2019 Nov 04, 2019	SELL	$159.77 - $178.1 $32,752 - $36,510	-205 Reduced 0.73%	27,753 $4.66 Million
Q2 2019 Aug 01, 2019	BUY	$144.16 - $172.9 $139,835 - $167,713	970 Added 3.59%	27,958 $4.83 Million
Q1 2019 Apr 29, 2019	BUY	$123.7 - $156.3 $120,607 - $152,392	975 Added 3.75%	26,988 $4.13 Million
Q4 2018 Feb 07, 2019	BUY	$120.82 - $174.09 $169,872 - $244,770	1,406 Added 5.71%	26,013 $3.29 Million
Q3 2018 Oct 23, 2018	BUY	$167.67 - $188.27 $174,879 - $196,365	1,043 Added 4.43%	24,607 $4.27 Million
Q2 2018 Jul 19, 2018	BUY	$160.33 - $189.41 $51,786 - $61,179	323 Added 1.39%	23,564 $4.23 Million
Q1 2018 Apr 30, 2018	SELL	$161.53 - $178.11 $23,906 - $26,360	-148 Reduced 0.63%	23,241 $3.76 Million
Q4 2017 Feb 09, 2018	BUY	$147.99 - $163.95 $216,953 - $240,350	1,466 Added 6.69%	23,389 $3.68 Million
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $3.28 Million - $3.52 Million	21,923	21,923 $3.31 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.86M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $23.2B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account